Table 3 Baseline characteristics of patient cohort
Median age | 67.0 years (range 24–84) |
Gender | Male 315 (73.8):female 112 (26.2) |
Histology | |
 Adenocarcinoma | 313 (73.3) |
 Squamous cell carcinoma | 100 (23.4) |
 Undifferentiated | 5 (1.2) |
 High-grade dysplasia | 4 (0.9) |
 Neuro-endocrine | 3 (0.7) |
 Small cell carcinoma | 1 (0.2) |
 Sarcoma | 1 (0.2) |
Tumour location | |
 Oesophagus | 268 (62.8) |
  Upper third | 14 (5.2) |
  Middle third | 71 (26.5) |
  Lower third | 183 (68.3) |
 Gastro-oesophageal junction | 159 (37.2) |
  Siewert I | 67 (42.1) |
  Siewert II | 42 (26.4) |
  Siewert III | 50 (31.4) |
Stage group | |
 IA | 10 (2.3) |
 IB | 17 (4.0) |
 IIA | 70 (16.4) |
 IIB | 13 (3.0) |
 IIIA | 97 (22.7) |
 IIIB | 52 (12.2) |
 IIIC | 76 (17.8) |
 IV | 92 (21.5) |
Treatment | |
 Curative | 224 (52.5) |
  NACT | 86 (38.4) |
  dCRT | 86 (38.4) |
  Surgery alone | 31 (13.8) |
  NACRT | 20 (8.9) |
  EMR | 1 (0.5) |
 Palliative | 203 (47.5) |
Mortality | |
 Alive | 132 (30.9) |
 Dead | 295 (69.1) |